Selecting the right analytical technology to support drug discovery research is critical. Although plate readers are well established, method development challenges related to reagent costs and labeling can slow down workflows. In comparison, mass spectrometry (MS) solutions yield benefits such as specificity and the ability to measure a more diverse range of compounds. Acoustic ejection MS (AEMS), being label-free, reduces the method development time, and also benefits from a low sample volume requirement and the accuracy of mass spectrometric detection.
Download this infographic to learn more about different analytical technologies and the benefits of AEMS for high-throughput drug discovery.
